Abstract
Most patients with type 2 diabetes ultimately need insulin therapy. This paper presents the case for starting insulin therapy sooner rather than later, preferably without oral drugs and in a "basal/bolus" regimen consisting of a daily dose of a long-acting insulin for basal coverage plus preprandial doses of a short-acting insulin.
Publication types
-
Research Support, Non-U.S. Gov't
-
Review
MeSH terms
-
Diabetes Mellitus, Type 2 / drug therapy*
-
Diabetes Mellitus, Type 2 / physiopathology
-
Disease Progression
-
Drug Administration Schedule
-
Humans
-
Hypoglycemic Agents / therapeutic use*
-
Insulin / therapeutic use*
-
Time Factors
Substances
-
Hypoglycemic Agents
-
Insulin